Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Introducing Rare Cannabinoid Company's Latest Innovation: THC + CBN Sleep Gummies for a Restful Night's Sleep


News provided by

Rare Cannabinoid Company

Nov 22, 2023, 03:48 ET

Share this article

Share toX

Share this article

Share toX

THC + CBN Sleep Gummies contain a full spectrum natural hemp oil that combines the benefits of relaxing Delta-9-THC with CBN oil for restful sleep and CBD oil. They ship to all U.S. locations.
THC + CBN Sleep Gummies contain a full spectrum natural hemp oil that combines the benefits of relaxing Delta-9-THC with CBN oil for restful sleep and CBD oil. They ship to all U.S. locations.

Rare Cannabinoid Company launches THC + CBN Sleep Gummies. These all-natural, vegan, hemp edibles are designed to promote a restful night's sleep. They combine the benefits of Delta-9-THC, CBN oil, and CBD oil into one huckleberry-flavored bedtime edible.

HONOLULU, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading provider of premium hemp-infused products, is thrilled to announce the launch of their newest product, THC + CBN Sleep Gummies. Crafted with care and designed to promote a restful night's sleep, these gummies are set to revolutionize the way people experience CBN products.

Sleep is essential for overall well-being, and many individuals struggle with sleep disturbances and overactive thoughts that keep them awake at night. THC + CBN Sleep Gummies offer a natural and effective option for those seeking a better night's sleep.

Many of our customers say they take our THC Mood Gummies along with our original extra strength CBN Gummies for a dreamy night's sleep, and we're happy to now offer a gummy with the benefits of both THC and CBN in one gummy.

Post this

Like the brand's extra strength CBN Gummies for Sleep, each gummy contains 30mg CBN for relaxation, rest, and sleep, as well as 10mg CBD oil for calm, balance, and the entourage effect. What's unique about these gummies is that they also contain 5mg Delta-9-THC to amplify the dreamy relaxing effects.

Key Features of THC + CBN Sleep Gummies:

  • Synergistic Formula: Gummies combine the power of Delta-9-THC (tetrahydrocannabinol) and CBN (cannabinol) to create a synergistic effect that may help users fall asleep faster and enjoy a more prolonged and uninterrupted sleep. CBD oil also enhances effects.

  • Precise Dosage: Each gummy is precisely dosed to ensure a consistent and reliable experience, making it easy for users to find their ideal dose for a restful night's sleep. Each gummy contains a full spectrum extract with 5mg hemp-derived Delta-9-THC oil, 30mg CBN oil, and 10mg CBD oil.

  • Premium Ingredients: Rare Cannabinoid Company uses only the highest-quality, all-natural, vegan ingredients in their gummies, with no artificial additives or preservatives.

  • Delicious Flavors: THC + CBN Sleep Gummies have a delicious, natural huckleberry flavor. This makes them a tasty and enjoyable way to unwind before bedtime.

  • Convenient Jar with Child-Resistant Lid: The THC + CBN Sleep Gummies are packaged in a convenient wide-necked jar with a child-resistant lid. This is for added safety, but these gummies should always be kept out of reach of children. They are for use by adults 21+ only.

  • Third-Party Lab Tests: All Rare Cannabinoid Company products undergo rigorous third-party testing to ensure they meet the highest quality and safety standards, providing peace of mind to customers.

  • Legal Delta-9-THC Gummies: The Delta-9-THC in THC + CBN Sleep Gummies comes in a full spectrum oil that is naturally extracted from legal U.S. hemp plants. It is not converted, synthesized, or isomerized from CBD or any other cannabinoid. There is less than 0.3% THC in the gummies and they are federally legal.

  • Ships To All 50 States: All Rare Cannabinoid Company products, including their line of THC gummies, ship to all locations across the United States. However, due to circumstances outside of their control, they cannot ship THC gummies outside the United States.

"We're thrilled to introduce our THC + CBN Sleep Gummies to the market," said a company spokesperson.

"Many of our customers say they take our THC Mood Gummies along with our original extra strength CBN Gummies for a dreamy night's sleep, and we're happy to now offer a gummy with the benefits of both THC and CBN in one gummy."

The THC + CBN Sleep Gummies are now available for purchase on their website as well as at some of the 400 locations that stock their products.

Rare Cannabinoid Company also offers oils and gummies of THCV for energy and appetite control, CBG Gummies for discomfort relief, and CBD Gummies for calm and balance. They are also releasing THC + CBG Relief Gummies and THC + THCV Uplift Gummies to add to their growing THC Gummies line.

For anyone who would like the sleepy benefits of CBN cannabinoid without THC, they also offer a pure CBN oil tincture, CBN CBD blend, as well as the extra strength CBN Gummies with CBD but no Delta-9-THC.

Rare Cannabinoid Company also offers a vast selection of rare cannabinoid oils, Hawaiian Choice CBD, Pet CBD, topical gel, and more.

To learn more about their latest product and commitment to quality, please visit http://www.rarecannabinoidco.com.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, +1 (808)762-1313, [email protected], www.rarecannabinoidco.com

SOURCE Rare Cannabinoid Company

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.